Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins

对记忆B细胞的分析鉴定出变异型SARS-CoV-2刺突蛋白N端结构域上的保守中和表位

阅读:13
作者:Zijun Wang ,Frauke Muecksch ,Alice Cho ,Christian Gaebler ,Hans-Heinrich Hoffmann ,Victor Ramos ,Shuai Zong ,Melissa Cipolla ,Briana Johnson ,Fabian Schmidt ,Justin DaSilva ,Eva Bednarski ,Tarek Ben Tanfous ,Raphael Raspe ,Kaihui Yao ,Yu E Lee ,Teresia Chen ,Martina Turroja ,Katrina G Milard ,Juan Dizon ,Anna Kaczynska ,Anna Gazumyan ,Thiago Y Oliveira ,Charles M Rice ,Marina Caskey ,Paul D Bieniasz ,Theodora Hatziioannou ,Christopher O Barnes ,Michel C Nussenzweig

Abstract

SARS-CoV-2 infection or vaccination produces neutralizing antibody responses that contribute to better clinical outcomes. The receptor-binding domain (RBD) and the N-terminal domain (NTD) of the spike trimer (S) constitute the two major neutralizing targets for antibodies. Here, we use NTD-specific probes to capture anti-NTD memory B cells in a longitudinal cohort of infected individuals, some of whom were vaccinated. We found 6 complementation groups of neutralizing antibodies. 58% targeted epitopes outside the NTD supersite, 58% neutralized either Gamma or Omicron, and 14% were broad neutralizers that also neutralized Omicron. Structural characterization revealed that broadly active antibodies targeted three epitopes outside the NTD supersite including a class that recognized both the NTD and SD2 domain. Rapid recruitment of memory B cells producing these antibodies into the plasma cell compartment upon re-infection likely contributes to the relatively benign course of subsequent infections with SARS-CoV-2 variants, including Omicron.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。